Research Paper Volume 15, Issue 17 pp 8744—8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Figure 12. The prognostic role of CLCN4 in UCEC. (A) Kaplan–Meier analysis of the OS between the tumor and normal tissues. (B) Kaplan–Meier analysis of the RFS between the two groups. (C, D) Ranked dot and scatter plots showing the CLCN4 distribution and patient survival status. Heatmaps show CLCN4 Expression patterns of CLCN4. ROC curves to predict the sensitivity and specificity of 1-, 3-, and 5-year survival according to the CLCN4.